GCG and type 2 diabetes mellitus: The glucagon pathway is suspected of being the target of BBR beyond the insulin pathway because abnormally elevated glucagon levels and increased hepatic glucagon sensitivity drive hepatic gluconeogenesis in type 2 diabetic patients [13].